Shares of Cardinal Health Inc. CAH advanced 1.82% to $127.45 Wednesday, on what proved to be an all-around great trading ...

Cardinal Health Inc.’s stock fell 4% early Monday, after the drug distributor and medical-laboratory products maker said its contracts with pharmacy-benefits manager OptumRx will expire at the ...

The stock's fall snapped a two-day winning streak.

Cardinal Health Inc (NYSE:CAH). shares have reached an unprecedented peak, touching an all-time high of $126.3. According to InvestingPro analysis, the stock remains undervalued despite this ...

Cardinal Health's opening of a new distribution center in Fort Worth, TX, can boost its stock price in the long run by improving efficiency, reducing delivery times, and meeting growing demand in ...

Cardinal Health (CAH) closed at $117.92 in the latest trading session, marking a -1.02% move from the prior day. The stock outperformed the S&P 500, which registered a daily loss of 1.07%.

Over the longer term, Cardinal’s performance looks even grimmer. CAH stock has gained 17.2% on a YTD basis and 9.3% over the past year, compared to DOWI’s 16.3% gains in 2024 and 18.2% returns ...

Cardinal Health (CAH) closed at $117.92 in the latest trading session, marking a -1.02% move from the prior day. The stock outperformed the S&P 500, which registered a daily loss of 1.07%. Elsewhere, ...